Position in VTRS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$15,672,908
+$484,944 QoQ
Shares Held
1,160,097
-4.9% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 96.5112400083786.ToString("F0")%
Shared 0.02017072710299225.ToString("F0")%
None 3.468589264518398.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Derivatives in VTRS
reported options exposure · as of Mar 31, 2021CallValue
$3,558,159
CallShares
254,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $924,834,595 across 59 Drug Manufacturers - Specialty & Generic names. VTRS ranks #8 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,491,173 | $649,111,558 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
77,138 | $45,741,289 | |
| 3 | HLN |
Haleon plc
|
4,022,749 | $40,267,716 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
231,311 | $30,472,908 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,136,022 | $21,039,125 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
805,422 | $19,273,746 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
300,133 | $17,788,881 | |
| 8 | VTRS |
Viatris Inc
This page
|
1,160,097 | $15,672,908 |
All Filings in VTRS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,672,908 | 1,160,097 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $15,187,964 | 1,219,917 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $16,134,463 | 1,629,744 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $16,733,773 | 1,873,883 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $17,334,901 | 1,990,230 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $28,445,957 | 2,284,816 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $35,043,529 | 3,018,392 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $32,961,768 | 3,100,825 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $36,415,553 | 3,049,879 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $31,435,090 | 2,902,594 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $30,955,171 | 3,139,470 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $38,466,211 | 3,854,330 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $37,070,773 | 3,853,511 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $34,958,304 | 3,140,908 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $29,990,756 | 3,520,042 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $39,259,703 | 3,749,733 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $49,678,742 | 4,566,061 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $64,554,632 | 4,771,222 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $96,540,265 | 7,124,743 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $99,753,014 | 6,980,617 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $105,719,259 | 7,567,592 | Shares | Defined | 2021-05-13 | |
| 2021-03-31 | $3,558,159 | 254,700 | Call | Defined | 2021-05-13 | |
| 2020-12-31 | $629,664 | 33,600 | Call | Defined | 2021-02-09 | |
| 2020-12-31 | $56,220 | 3,000 | Put | Defined | 2021-02-09 | |
| 2020-12-31 | $100,305,584 | 5,352,486 | Shares | Defined | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||